Aug. 13, 2025 — A new study from Denmark shows for the first time that men with biochemically recurrent prostate cancer who undergo PSMA PET/CT before salvage radiotherapy have improved survival rates compared to those who do not. Using data collected nationwide over a period of eight years, researchers confirmed that PSMA PET/CT is a valuable tool for identifying patients who are likely to benefit from salvage radiotherapy. This research was published in the August issue of The Journal of Nuclear Medicine.
English (US) ·